Digoxin: Revision history

31 March 2014

• curprev 17:5917:59, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,550 bytes −33‎ →‎Pharmacology
• curprev 17:5817:58, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,583 bytes −11‎ →‎Pharmacology
• curprev 16:4816:48, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,594 bytes +216‎ →‎Contraindications
• curprev 16:3816:38, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,378 bytes +1,827‎ →‎Use in Specific Populations
• curprev 16:1616:16, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 38,551 bytes +216‎ No edit summary
• curprev 16:1416:14, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 38,335 bytes −28‎ →‎Mechanism of Action
• curprev 16:1316:13, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 38,363 bytes +9,508‎ →‎Pharmacology
• curprev 15:5315:53, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 28,855 bytes +1,351‎ →‎Patient Information from FDA
• curprev 15:0515:05, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 27,504 bytes +1,460‎ →‎Use in Specific Populations
• curprev 15:0215:02, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 26,044 bytes +2,825‎ →‎Drug Interactions
• curprev 14:5914:59, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 23,219 bytes +1,017‎ →‎Adverse Reactions
• curprev 14:5614:56, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 22,202 bytes +1,622‎ →‎Non–Guideline-Supported Use
• curprev 14:5514:55, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 20,580 bytes +377‎ →‎FDA-Labeled Indications and Dosage (Pediatric)
• curprev 14:4714:47, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 20,203 bytes +779‎ No edit summary

27 March 2014

• curprev 18:5818:58, 27 March 2014‎ Abdurahman Khalil talk contribs‎ 19,424 bytes 0‎ No edit summary
• curprev 18:5718:57, 27 March 2014‎ Abdurahman Khalil talk contribs‎ 19,424 bytes +5,671‎ No edit summary
• curprev 16:5316:53, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,753 bytes +21‎ →‎Overview
• curprev 12:5512:55, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,732 bytes +20‎ →‎Overview
• curprev 12:5412:54, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,712 bytes −1‎ No edit summary
• curprev 12:5312:53, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,713 bytes −20‎ No edit summary
• curprev 12:5312:53, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,733 bytes +12,382‎ No edit summary

26 March 2014

• curprev 17:2217:22, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 1,351 bytes 0‎ No edit summary
• curprev 17:1317:13, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 1,351 bytes −3,183‎ No edit summary
• curprev 17:1217:12, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 4,534 bytes −25‎ →‎Lanoxin (digoxin) tablet
• curprev 17:1017:10, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 4,559 bytes −14‎ No edit summary

25 March 2014

• curprev 15:1815:18, 25 March 2014‎ Abdurahman Khalil talk contribs‎ 4,573 bytes +2‎ No edit summary
• curprev 12:4712:47, 25 March 2014‎ GeraldChi talk contribs‎ 4,571 bytes −57‎ No edit summary
• curprev 12:4612:46, 25 March 2014‎ GeraldChi talk contribs‎ 4,628 bytes −65‎ →‎Category

20 March 2014

• curprev 14:4814:48, 20 March 2014‎ Abdurahman Khalil talk contribs‎ 4,693 bytes +60‎ No edit summary
• curprev 14:4414:44, 20 March 2014‎ Abdurahman Khalil talk contribs‎ 4,633 bytes 0‎ No edit summary
• curprev 14:4214:42, 20 March 2014‎ Abdurahman Khalil talk contribs‎ 4,633 bytes −888‎ No edit summary

28 February 2014

• curprev 16:0116:01, 28 February 2014‎ Abdurahman Khalil talk contribs‎ 5,521 bytes +1,719‎ →‎Mechanism of Action

27 February 2014

• curprev 19:3419:34, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,802 bytes 0‎ No edit summary
• curprev 19:2919:29, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,802 bytes +216‎ →‎References
• curprev 19:2619:26, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,586 bytes +28‎ →‎US Brand Names
• curprev 19:2519:25, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,558 bytes +1,368‎ →‎FDA Package Insert

22 February 2014

• curprev 21:0821:08, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,190 bytes +24‎ →‎Category
• curprev 21:0721:07, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,166 bytes +1‎ →‎Overview
• curprev 21:0621:06, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,165 bytes −53‎ →‎Overview
• curprev 21:0421:04, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,218 bytes +858‎ →‎Overview
• curprev 20:2420:24, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 1,360 bytes +16‎ No edit summary

29 January 2014

• curprev 23:4523:45, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,344 bytes +54‎ No edit summary
• curprev 23:3923:39, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,290 bytes +34‎ No edit summary
• curprev 23:3823:38, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,256 bytes +15‎ No edit summary
• curprev 23:3823:38, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,241 bytes −7,562‎ No edit summary

24 September 2012

• curprev 00:2300:23, 24 September 2012‎ C Michael Gibson talk contribs‎ 8,803 bytes −930‎ No edit summary

23 September 2012

• curprev 17:5217:52, 23 September 2012‎ Prashanthsaddala talk contribs‎ 9,733 bytes +907‎ No edit summary
• curprev 17:5217:52, 23 September 2012‎ Prashanthsaddala talk contribs‎ 8,826 bytes +25‎ →‎Dosing and Administration
• curprev 16:0716:07, 23 September 2012‎ Kristin Feeney talk contribs‎ m 8,801 bytes 0‎ Changed protection level for "Digoxin" ([edit=autoconfirmed] (indefinite) [move=autoconfirmed] (indefinite))

27 September 2011

• curprev 17:3317:33, 27 September 2011‎ Matt Pijoan talk contribs‎ m 8,801 bytes +8,801‎ Protected "Digoxin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))